MedPath

BUSPIRONE HCl

Buspirone HCl Tablets USP Revised: October 2007 Rx only

Approved
Approval ID

b534c251-f15c-4831-96b8-d496fd916c23

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 19, 2011

Manufacturers
FDA

STAT RX USA LLC

DUNS: 786036330

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

BUSPIRONE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16590-579
Application NumberANDA074253
Product Classification
M
Marketing Category
C73584
G
Generic Name
BUSPIRONE HYDROCHLORIDE
Product Specifications
Route of AdministrationORAL
Effective DateMay 19, 2011
FDA Product Classification

INGREDIENTS (6)

COLLOIDAL SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
BUSPIRONE HYDROCHLORIDEActive
Quantity: 15 mg in 1 1
Code: 207LT9J9OC
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BUSPIRONE HCl - FDA Drug Approval Details